Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-7-19
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0168-8278
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
264-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1646837-Chronic Disease,
pubmed-meshheading:1646837-Hepacivirus,
pubmed-meshheading:1646837-Hepatitis Antibodies,
pubmed-meshheading:1646837-Hepatitis C,
pubmed-meshheading:1646837-Humans,
pubmed-meshheading:1646837-Interferon Type I,
pubmed-meshheading:1646837-Recombinant Proteins
|
pubmed:year |
1991
|
pubmed:articleTitle |
Antibodies to hepatitis C virus and response to interferon treatment in non-A, non-B chronic hepatitis.
|
pubmed:publicationType |
Letter,
Comment
|